No CrossRef data available.
Published online by Cambridge University Press: 15 May 2009
In trials with polyvalent commercial influenza vaccines the antibody responses to oil-adjuvant vaccine persisted longer and were often higher. Antibody conversion was poor after all vaccines and delayed after adjuvant.